AnaptysBio Inc buy Guggenheim
Start price
18.12.25
/
50%
€40.20
Target price
18.12.26
-
Performance (%)
1.99%
Price
12.01.26
€41.40
Summary
This prediction is currently active. The BUY prediction by Guggenheim shows slight gains of 1.99%. This prediction currently runs until 18.12.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| AnaptysBio Inc | 3.825% |
| iShares Core DAX® | 2.331% |
| iShares Nasdaq 100 | 2.077% |
| iShares Nikkei 225® | 2.759% |
| iShares S&P 500 | 1.613% |
Comments by Guggenheim for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio (NASDAQ:ANAB) had its "buy" rating reaffirmed by analysts at Guggenheim.
Ratings data for ANAB provided by MarketBeat